F279-0330 Screening compound: 6-{[2-(2,4-dimethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-4-(4-methoxyphenyl)-3-methyl-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-7-one

F279-0330 Screening compound: 6-{[2-(2,4-dimethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-4-(4-methoxyphenyl)-3-methyl-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-7-one
F279-0330 Screening compound: 6-{[2-(2,4-dimethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-4-(4-methoxyphenyl)-3-methyl-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-7-one alternative view

Chemical Structure Depiction of ChemDiv screening compound F279-0330
6-{[2-(2,4-dimethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-4-(4-methoxyphenyl)-3-methyl-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-7-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F279-0330

Molecular Formula

C26H24N4O6 (C26 H24 N4 O6)

Compound Name

6-{[2-(2,4-dimethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-4-(4-methoxyphenyl)-3-methyl-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-7-one

IUPAC name

6-{[2-(24-dimethoxyphenyl)-5-methyl-13-oxazol-4-yl]methyl}-4-(4-methoxyphenyl)-3-methyl-6H7H-[12]oxazolo[34-d]pyridazin-7-one

SMILES

Cc1c(CN(C(c2noc(C)c22)=O)N=C2c(cc2)ccc2OC)nc(-c(ccc(OC)c2)c2OC)o1

InChI

InChI=1S/C26H24N4O6/c1-14-20(27-25(35-14)19-11-10-18(33-4)12-21(19)34-5)13-30-26(31)24-22(15(2)36-29-24)23(28-30)16-6-8-17(32-3)9-7-16/h6-12H,13H2,1-5H3

InChI Key

RMIMWHWQVLBCIG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14947040

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

488.5

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.572

Distribution Coefficient, logD

3.570

Water Solubility, LogSw

-3.95

Polar Surface Area

90.358

Acid Dissociation Constant (pKa)

25.83

Base Dissociation Constant (pKb)

4.98

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.10

F279-0330 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

Neuropeptide S Library (2850 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Digestive system
  • Nervous system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F279-0330 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F279-0330?
Check Price and Availability of F279-0330, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F279-0330 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F279-0330
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F279-0330
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F279-0330 available by request